Examination of Predictors of Pain at 12 Months Postdiagnosis in Head and Neck Cancer Survivors.
cancer survivorship
chronic pain
head and neck cancer
health-related quality of life
psycho-oncology
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
02
06
2023
received:
06
03
2023
accepted:
17
06
2023
medline:
22
11
2023
pubmed:
5
7
2023
entrez:
5
7
2023
Statut:
ppublish
Résumé
Pain following the completion of treatment is important but has received less attention in the head and neck cancer (HNC) literature. The present study sought to examine the prevalence and predictors of pain measured 12 months postdiagnosis and its impact on HNC-specific health-related quality of life (HRQOL) in 1038 HNC survivors. Prospective observational study. Single-institution tertiary care center. Pain was measured using a single item ranging from 0 to 10 with 0 representing no pain and 10 representing the worst pain possible. Self-reported depressive symptomatology was measured using the Beck Depression Inventory and self-reported problem alcohol use was measured by the Short Michigan Alcoholism Screening Test. HNC-specific HRQOL was measured using the Head and Neck Cancer Inventory (HNCI). Hierarchical multivariable linear regression analyses indicated that in addition to pain at 3 months postdiagnosis (β = .145, t = 3.18, sr Pain in patients with HNC is a considerable issue at 12 months postdiagnosis, deserving further attention. Behavioral factors such as depression and problem alcohol use may be associated with pain and require systematic screening over time to identify and treat issues that impact optimal long-term recovery from HNC, including disease-specific HRQOL.
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1506-1512Informations de copyright
© 2023 Published 2023. This article is a U.S. Government work and is in the public domain in the USA.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489-501.
Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. The Lancet. 2008;371:1695-1709.
Howren MB, Christensen AJ, Karnell LH, Funk GF. Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol. 2013;81:299-317.
Bossi P, Giusti R, Tarsitano A, et al. The point of pain in head and neck cancer. Crit Rev Oncol Hematol. 2019;138:51-59.
Scharpf J, Karnell LH, Christensen AJ, Funk GF. The role of pain in head and neck cancer recurrence and survivorship. Arch Otolaryngol Head Neck Surg. 2009;135(8):789-794.
Ren JL, Rojo RD, Perez JVD, Yeung SCJ, Hanna EY, Reyes-Gibby CC. Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors. BMC Cancer. 2021;21(1):1304.
van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437-1449.
Villa A, Sonis S. Toxicities associated with head and neck cancer treatment and oncology-related clinical trials. Curr Probl Cancer. 2016;40(5-6):244-257.
Cramer JD, Johnson JT, Nilsen ML. Pain in head and neck cancer survivors: prevalence, predictors, and quality-of-life impact. Otolaryngol Head Neck Surg. 2018;159(5):853-858.
Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain. 2014;15:1015-1022.
Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138:123-133.
Logan HL, Bartoshuk LM, Fillingim RB, Tomar SL, Mendenhall WM. Metallic taste phantom predicts oral pain among 5-year survivors of head and neck cancer. Pain. 2008;140(2):323-331.
Ye Y, Jensen DD, Viet CT, et al. Advances in head and neck cancer pain. J Dent Res. 2022;101(9):1025-1033.
Glare PA, Davies PS, Finlay E, et al. Pain in cancer survivors. J Clin Oncol. 2014;32(16):1739-1747.
Logan HL, Fillingim RB, Bartoshuk LM, et al. Smoking status and pain level among head and neck cancer patients. J Pain. 2010;11(6):528-534.
Shuman AG, Terrell JE, Light E, et al. Predictors of pain among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138(12):1147-1154.
Marziliano A, Teckie S, Diefenbach MA. Alcohol-related head and neck cancer: summary of the literature. Head Neck. 2020;42:732-738.
Burris JL, Studts JL, DeRosa AP, Ostroff JS. Systematic review of tobacco use after lung or head/neck cancer diagnosis: results and recommendations for future research. Cancer Epidemiol Biomarkers Prev. 2015;24:1450-1461.
Howren MB, Christensen AJ, Karnell LH, Funk GF. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms. Health Psychol. 2010;29:65-71.
Hammerlid E, Silander E, Hrnestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head Neck. 2001;23:113-125.
Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1):9-19.
Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17-24.
Funk GF, Karnell LH, Christensen AJ, Moran PJ, Ricks J. Comprehensive head and neck oncology health status assessment. Head Neck. 2003;25:561-575.
Funk GF, Karnell LH, Smith RB, Christensen AJ. Clinical significance of health status assessment measures in head and neck cancer: what do quality-of-life scores mean? Arch Otolaryngol Head Neck Surg. 2004;130:825-829.
Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100.
Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology. 2004;13:269-280.
Selzer ML, Vinokur A, van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol. 1975;36:117-126.
Van Liew JR, Brock RL, Christensen AJ, Karnell LH, Pagedar NA, Funk GF. Weight loss after head and neck cancer: a dynamic relationship with depressive symptoms. Head Neck. 2017;39:370-379.
Minnich A, Erford BT, Bardhoshi G, Atalay Z, Chang CY, Muller LA. Systematic evaluation of psychometric characteristics of the Michigan Alcoholism Screening Test 13-item Short (SMAST) and 10-item Brief (BMAST) versions. J Counseling Dev. 2019;97:15-24.
Piccirillo JF. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441-2447.
Bianchini C, Maldotti F, Crema L, Malagò M, Ciorba A. Pain in head and neck cancer: prevalence and possible predictive factors. J Balkan Union Oncol. 2014;19(3):592-597.
Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016;34(27):3325-3345.
Ghei A, Khot S. Pain management in patients with head and neck carcinoma. Int J Otorhinolaryngol Clin. 2010;2(1):69-75.
Moore RJ, Chamberlain RM, Khuri FR. A qualitative study of head and neck cancer. Supp Care Cancer. 2004;12(5):338-346.
Lydiatt WM, Moran J, Burke WJ. A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol. 2009;7:397-403.
Karnell LH, Funk GF, Christensen AJ, Rosenthal EL, Magnuson JS. Persistent posttreatment depressive symptoms in patients with head and neck cancer. Head Neck. 2006;28:453-461.
Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32:1605-1619.
Goyal N, Day A, Epstein J, et al. Head and neck cancer survivorship consensus statement from the American Head and Neck Society. Laryngoscope Investig Otolaryngol. 2022;7(1):70-92.
Dimon EL, Simmons JK, Ziegler A, et al. Assessment of conditions leading to lost-to-follow-up of head and neck cancer patients. Am J Otolaryngol. 2022;43:103443.
Seaman AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, Kendell ND, Pagedar NA. Characterizing head and neck cancer survivors' discontinuation of survivorship care. Cancer. 2022;128:192-202.
Howren MB, Christensen AJ, Pagedar NA. Examination of risk factors for discontinuation of follow-up care in patients with head and neck cancer. Cancer Med. 2023;12:631-639.
Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF. Continued alcohol use in patients with head and neck cancer. Head Neck. 2010;32:905-912.
Howren MB, Christensen AJ, Adamowicz JL, Seaman A, Wardyn S, Pagedar NA. Problem alcohol use among rural head and neck cancer patients at diagnosis: associations with health-related quality of life. Psycho-Oncology. 2021;30(5):708-715.
McCarter K, Baker AL, Britton B, et al. Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy. Cancer Med. 2018;7:2382-2390.
LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and cancer: a statement of the American Society of Clinical Oncology. J Clin Oncol. 2018;36:83-93.
O'Donnell K, Wardle J, Dantzer C, Steptoe A. Alcohol consumption and symptoms of depression in young adults from 20 countries. J Stud Alcohol. 2006;67:837-840.
Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prevent. 2006;15:2203-2208.
Vander Weg MW, Cozad AJ, Howren MB, et al. An individually-tailored smoking cessation intervention for rural veterans: a pilot randomized trial. BMC Public Health. 2016;16:811.
Mazul AL, Chidambaram S, Zevallos JP, Massa ST. Disparities in head and neck cancer incidence and trends by race/ethnicity and sex. Head Neck. 2023;45:75-84.